Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Calithera Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 23 | −5 |
| Shares | 1.75M | 40 | 1.65M | −102.3K (−5.8%) |
| Value | $4.44M | $0 | $5.02M | +$585.5K (+13.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Calithera Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 1,206 | $3.55K | 0.00% |
| Axiom Investment Management LLC | 250 | $0 | 0.00% |
Sold out (7)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Alyeska Investment Group, L.P. | 50,000 | $123.0K |
| Two Sigma Investments, LP | 19,947 | $49.0K |
| Virtu Financial LLC | 15,456 | $38.0K |
| D. E. Shaw & Co., Inc. | 11,249 | $28.0K |
| Susquehanna International Group, LLP | 10,177 | $25.0K |
| Tarbox Family Office, Inc. | 10,000 | $25.0K |
| Lindbrook Capital, LLC | 500 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cordasco Financial Network | 40 | $0 |